email other
Medicare GLP-1 Bridge — technical program questions only
No phone listed for this route
Published emailTechnical questions about the CMS demonstration; do not include personally identifiable information or protected health information.
Published hoursNot published in this record
Confirm the exact product or service
National contact — confirm product and location
Not researched for this route
Not a patient case, prescription, PAP or prior-authorization submission inbox. If secure transfer is necessary, follow CMS instructions to arrange it. Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.
View source ↗ · Source checked 2026-10-23 · Source revision Provider page last modified August 6, 2026.
Report an update